Øresund Pharma ApS: Financial statements 2019
CVR: 39492059
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 4,932,387 and a net result of DKK 2,568,553. Equity in the 2019 report amounted to DKK 2,695,409. The solvency ratio was 18.7%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 4,932,387
- Profit/Loss
- DKK 2,568,553
- Equity
- DKK 2,695,409
- Total Assets
- DKK 14,444,236
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Øresund Pharma ApS has published its interim report for the period April 17, 2018 – December 31, 2018.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.